All Stories

  1. Impact of childhood malnutrition and intestinal microbiota on MDR infections

    Article • JAC-Antimicrobial Resistance, March 2023, Oxford University Press (OUP)

    David van Duin

  2. Serious Infections

    Article • July 2022, Cambridge University Press

    David van Duin

  3. Fungal Infections in Transplant Recipients

    Article • January 2021, Elsevier

    David van Duin

  4. Emerging Epidemics in Transplant: Histoplasmosis, Blastomycosis, and Paracoccidioidomycosis

    Article • January 2021, Springer Science + Business Media

    David van Duin

  5. The impact of the COVID-19 pandemic on antimicrobial resistance: a debate

    Article • JAC-Antimicrobial Resistance, July 2020, Oxford University Press (OUP)

    David van Duin

  6. Innovative strategies to fight antimicrobial resistance: crowdsourcing to expand medical training

    Article • F1000Research, April 2020, Faculty of 1000, Ltd.

    Jason Ong, Rosanna Peeling, David van Duin, Jehan Budak, Eneyi Kpokiri

  7. Emerging Epidemics in Transplant: Histoplasmosis, Blastomycosis, and Paracoccidioidomycosis

    Article • January 2020, Springer Science + Business Media

    David van Duin

  8. Carbapenemase-producing organisms in solid organ transplantation

    Article • Current Opinion in Organ Transplantation, August 2019, Wolters Kluwer Health

    David van Duin

  9. Current trends in the treatment of pneumonia due to multidrug-resistant Gram-negative bacteria

    Article • F1000Research, February 2019, Faculty of 1000, Ltd.

    David van Duin

  10. Current trends in the treatment of pneumonia due to multidrug-resistant Gram-negative bacteria

    Article • F1000Research, January 2019, Faculty of 1000, Ltd.

    David van Duin

  11. Preface

    Article • Journal of Antimicrobial Chemotherapy, March 2018, Oxford University Press (OUP)

    David van Duin

  12. Risk Factors for Healthcare-Associated Infections in Adult Burn Patients

    Article • Infection Control, October 2017, Cambridge University Press

    David van Duin

  13. China's antibiotic resistance problems

    Article • The Lancet Infectious Diseases, April 2017, Elsevier

    David van Duin

  14. Novel Beta-Lactamase Inhibitors: Unlocking Their Potential in Therapy

    Article • Drugs, March 2017, Springer Science + Business Media

    David van Duin

  15. Preface

    Article • Journal of Antimicrobial Chemotherapy, March 2017, Oxford University Press (OUP)

    David van Duin

  16. Multidrug-Resistant Pseudomonas aeruginosa Infection in a Child with Cystic Fibrosis

    Article • Antimicrobial Agents and Chemotherapy, September 2016, ASM Journals

    David van Duin

  17. The global epidemiology of carbapenemase-producing Enterobacteriaceae

    Article • Virulence, August 2016, Taylor & Francis

    David van Duin

  18. Serious infections in the elderly

    Article • June 2016, Cambridge University Press

    David van Duin

  19. Spectrum of excess mortality due to carbapenem-resistant Klebsiella pneumoniae infections

    Article • Clinical Microbiology and Infection, June 2016, Elsevier

    David van Duin

  20. Multidrug-Resistant Bacteria in the Community

    Article • Infectious Disease Clinics of North America, June 2016, Elsevier

    David van Duin

  21. Hospital Readmissions in Patients With Carbapenem-Resistant Klebsiella pneumoniae

    Article • Infection Control, December 2015, Cambridge University Press

    David van Duin

  22. Outbreak of Colistin-Resistant, Carbapenemase-Producing Klebsiella pneumoniae: Are We at the End of the Road?

    Article • Journal of Clinical Microbiology, July 2015, ASM Journals

    David van Duin

  23. Community-Acquired Pyelonephritis in Pregnancy Caused by KPC-Producing Klebsiella pneumoniae

    Article • Antimicrobial Agents and Chemotherapy, July 2015, ASM Journals

    David van Duin

  24. Residence in Skilled Nursing Facilities Is Associated with Tigecycline Nonsusceptibility in Carbapenem-Resistant Klebsiella pneumoniae

    Article • Infection Control and Hospital Epidemiology, May 2015, Cambridge University Press

    David van Duin

  25. Impact of therapy and strain type on outcomes in urinary tract infections caused by carbapenem-resistant Klebsiella pneumoniae

    Article • Journal of Antimicrobial Chemotherapy, December 2014, Oxford University Press (OUP)

    David van Duin

  26. Tigecycline therapy for carbapenem-resistant Klebsiella pneumoniae (CRKP) bacteriuria leads to tigecycline resistance

    Article • Clinical Microbiology and Infection, December 2014, Elsevier

    David van Duin

  27. Genomic and Transcriptomic Analyses of Colistin-Resistant Clinical Isolates of Klebsiella pneumoniae Reveal Multiple Pathways of Resistance

    Article • Antimicrobial Agents and Chemotherapy, November 2014, ASM Journals

    Dr Michael R Jacobs, David van Duin

  28. Carbapenem-Resistant Klebsiella pneumoniae Urinary Tract Infection following Solid Organ Transplantation

    Article • Antimicrobial Agents and Chemotherapy, November 2014, ASM Journals

    David van Duin

  29. Healthcare-Associated Infections among Patients in a Large Burn Intensive Care Unit: Incidence and Pathogens, 2008–2012

    Article • Infection Control and Hospital Epidemiology, October 2014, Cambridge University Press

    David van Duin

  30. Erratum for Wright et al., Population Structure of KPC-Producing Klebsiella pneumoniae Isolates from Midwestern U.S. Hospitals

    Article • Antimicrobial Agents and Chemotherapy, September 2014, ASM Journals

    Dr Michael R Jacobs, David van Duin

  31. Reduction in Central Line–Associated Bloodstream Infections in Patients with Burns

    Article • Infection Control, August 2014, Cambridge University Press

    David van Duin

  32. Complex prosthetic joint infections due to carbapenemase-producing Klebsiella pneumoniae: a unique challenge in the era of untreatable infections

    Article • International Journal of Infectious Diseases, August 2014, Elsevier

    David van Duin

  33. Population Structure of KPC-Producing Klebsiella pneumoniae Isolates from Midwestern U.S. Hospitals

    Article • Antimicrobial Agents and Chemotherapy, June 2014, ASM Journals

    Dr Michael R Jacobs, David van Duin

  34. Surveillance of Carbapenem-Resistant Klebsiella pneumoniae: Tracking Molecular Epidemiology and Outcomes through a Regional Network

    Article • Antimicrobial Agents and Chemotherapy, May 2014, ASM Journals

    David van Duin, Dr Michael R Jacobs

  35. The impact of multidrug resistance on outcomes in ventilator-associated pneumonia

    Article • American Journal of Infection Control, May 2014, Elsevier

    David van Duin

  36. A High Performance Biomarker Detection Method for Exhaled Breath Mass Spectrometry Data

    Article • January 2014, Springer Science + Business Media

    David van Duin

  37. KIR and HLA Interactions Are Associated With Control of Primary CMV Infection in Solid Organ Transplant Recipients

    Article • American Journal of Transplantation, November 2013, Wiley

    David van Duin

  38. Functional Polymorphisms in the Gene Encoding Macrophage Migration Inhibitory Factor Are Associated With Gram-Negative Bacteremia in Older Adults

    Article • The Journal of Infectious Diseases, October 2013, Oxford University Press (OUP)

    David van Duin

  39. OqxAB, a Quinolone and Olaquindox Efflux Pump, Is Widely Distributed among Multidrug-Resistant Klebsiella pneumoniae Isolates of Human Origin

    Article • Antimicrobial Agents and Chemotherapy, July 2013, ASM Journals

    David van Duin

  40. Whipple’s Disease

    Article • Infectious Diseases in Clinical Practice, May 2013, Wolters Kluwer Health

    David van Duin

  41. Carbapenem-resistant Enterobacteriaceae: A menace to our most vulnerable patients

    Article • Cleveland Clinic Journal of Medicine, April 2013, Cleveland Clinic Journal of Medicine

    David van Duin

  42. Vaccines, 6th Edition

    Article • Clinical Infectious Diseases, March 2013, Oxford University Press (OUP)

    David van Duin

  43. Multidrug-Resistant Gram-Negative Bacteria Infections in Solid Organ Transplantation

    Article • American Journal of Transplantation, March 2013, Elsevier

    David van Duin

  44. Carbapenem-resistant Enterobacteriaceae: a review of treatment and outcomes

    Article • Diagnostic Microbiology and Infectious Disease, February 2013, Elsevier

    David van Duin

  45. Characteristics of Transplant Recipients Who Developed Influenza in 2007-08 Despite Influenza Vaccination

    Article • Journal of Vaccines & Vaccination, January 2013, OMICS Publishing Group

    David van Duin

  46. Experience with Fosfomycin for Treatment of Urinary Tract Infections Due to Multidrug-Resistant Organisms

    Article • Antimicrobial Agents and Chemotherapy, August 2012, ASM Journals

    David van Duin

  47. Challenges of Interferon-γ Release Assay Conversions in Serial Testing of Health-care Workers in a TB Control Program

    Article • CHEST Journal, July 2012, Elsevier

    David van Duin

  48. Endovascular Infections Caused by Histoplasma capsulatum: A Case Series and Review of the Literature

    Article • Archives of Pathology & Laboratory Medicine, June 2012, Archives of Pathology and Laboratory Medicine

    David van Duin

  49. Postoperative Fever and Infection in Immunosuppressed Patients

    Article • May 2012, Springer Science + Business Media

    David van Duin

  50. Staphylococcus Aureus Bacteremia in Solid Organ Transplant Recipients

    Article • Transplantation, May 2012, Wolters Kluwer Health

    David van Duin, Maricar Malinis

  51. Increased Rate of Spontaneous Bacterial Peritonitis Among Cirrhotic Patients Receiving Pharmacologic Acid Suppression

    Article • Clinical Gastroenterology and Hepatology, April 2012, Elsevier

    David van Duin, Dr Abhishek Deshpande

  52. Clinical Presentation and Management of Histoplasmosis in Older Adults

    Article • Journal of the American Geriatrics Society, January 2012, Wiley

    David van Duin

  53. Diagnostic Challenges and Opportunities in Older Adults With Infectious Diseases

    Article • Clinical Infectious Diseases, December 2011, Oxford University Press (OUP)

    David van Duin

  54. Effect of the influenza A (H1N1) live attenuated intranasal vaccine on nitric oxide (FE NO ) and other volatiles in exhaled breath

    Article • Journal of Breath Research, July 2011, Institute of Physics Publishing

    David van Duin

  55. Cytomegalovirus Viremia, Pneumonitis, and Tocilizumab Therapy

    Article • Emerging Infectious Diseases, April 2011, Centers for Disease Control and Prevention (CDC)

    David van Duin

  56. Cytomegalovirus Viremia, Pneumonitis, and Tocilizumab Therapy

    Article • Emerging Infectious Diseases, April 2011, Centers for Disease Control and Prevention (CDC)

    David van Duin

  57. Treatment and outcomes in carbapenem-resistant Klebsiella pneumoniae bloodstream infections

    Article • Diagnostic Microbiology and Infectious Disease, April 2011, Elsevier

    David van Duin

  58. Extreme alkaline phosphatase elevation associated with tigecycline

    Article • Journal of Antimicrobial Chemotherapy, February 2011, Oxford University Press (OUP)

    David van Duin

  59. Nontuberculous mycobacterial blood stream and cardiac infections in patients without HIV infection

    Article • Diagnostic Microbiology and Infectious Disease, July 2010, Elsevier

    David van Duin

  60. Effect Of The Influenza A (H1N1) Live Attenuated Intranasal Vaccination On Exhaled Nitric Oxide (NO) In Healthy Adult Healthcare Workers

    Article • May 2010, American Thoracic Society

    David van Duin

  61. S1915 Proton Pump Inhibitor (PPI) use is Associated With Spontaneous Bacterial Peritonitis (SBP) in Cirrhosis (Cir)

    Article • Gastroenterology, May 2010, Elsevier

    David van Duin

  62. Age-Associated Decrease in TLR Function in Primary Human Dendritic Cells Predicts Influenza Vaccine Response

    Article • The Journal of Immunology, March 2010, The American Association of Immunologists

    David van Duin

  63. Reply to Hage et al

    Article • Clinical Infectious Diseases, January 2010, Oxford University Press (OUP)

    David van Duin

  64. Recommended curriculum for subspecialty training in transplant infectious disease on behalf of the American Society of Transplantation Infectious Diseases Community of Practice Educational Initiatives Working Group

    Article • Transplant Infectious Disease, December 2009, Wiley

    David van Duin

  65. Histoplasmosis in Solid Organ Transplant Recipients: 10 Years of Experience at a Large Transplant Center in an Endemic Area

    Article • Clinical Infectious Diseases, September 2009, Oxford University Press (OUP)

    David van Duin

  66. Toll‐Like Receptors in Older Adults

    Article • Journal of the American Geriatrics Society, July 2007, Wiley

    David van Duin

  67. Prevaccine Determination of the Expression of Costimulatory B7 Molecules in Activated Monocytes Predicts Influenza Vaccine Responses in Young and Older Adults

    Article • The Journal of Infectious Diseases, June 2007, Oxford University Press (OUP)

    David van Duin

  68. Triggering TLR signaling in vaccination

    Article • Trends in Immunology, January 2006, Elsevier

    David van Duin

  69. Blastomyces dermatitidis produces melanin in vitro and during infection

    Article • FEMS Microbiology Letters, October 2004, Oxford University Press (OUP)

    Dr Arturo Casadevall, David van Duin

  70. Effects of Voriconazole on Cryptococcus neoformans

    Article • Antimicrobial Agents and Chemotherapy, June 2004, ASM Journals

    David van Duin

  71. Melanization of Cryptococcus neoformans and Histoplasma capsulatum Reduces Their Susceptibilities to Amphotericin B and Caspofungin

    Article • Antimicrobial Agents and Chemotherapy, November 2002, ASM Journals

    David van Duin

  72. Seizures in the Critically Ill: The Role of Imipenem

    Article • Epilepsia, December 2001, Wiley

    David van Duin